Ofloxacin otic solution 0.3% [Floxin Otic Singles] has been launched in the US by Daiichi Pharmaceutical.

Source: Inpharma, Volume 1, Number 1437, 2004-05-15 , pp. 22-22(1)

Keywords: Daiichi-Pharmaceutical; Development-status; Ofloxacin, therapeutic use; Otorhinolaryngological-infections, treatment; Product-launches

Document Type: Short communication

Links for this article

http://www.ingentaconnect.com/adis/inp/2004/00000001/00001437/art00064
http://openurl.ingenta.com/content?genre=article&issn=1173-8324&volume=1&issue=1437&spage=22&epage=22